AdderaCare (ADDERA.ST) Stock Analysis & AI Equity Report
AdderaCare (ADDERA.ST) overview
AdderaCare (ADDERA.ST) stock analysis and AI equity research. For the latest completed financial year, 2021, AdderaCare reported revenue of SEK 248m and operating profit of SEK 3.4m; the year-end share price was N/A and market capitalisation was N/A. AdderaCare is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get AdderaCare's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-08-30. Data will be refreshed during report generation.
About AdderaCare
AdderaCare AB is a Swedish group active in the assistive technology sector. Through its subsidiaries, it develops, markets and sells products and solutions for people with functional impairments, including ramps, adapted lifts, vehicle solutions and other assistive devices. The group also provides sensory-stimulation tools and motor skills training, with growth driven by acquisitions and operating subsidiaries.
Generate the AdderaCare report
AdderaCare is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for AdderaCare and represent the latest completed financial year (2021). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.